The Patent Finder

Terms ending in 2043

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,617,795SUBSTITUTED 6,7-Dihydro-5H-PYRROLO[3,4-d]PYRIMIDINES, 5,7-Dihydrofuro[3,4-d]PYRIMIDINES, AND PYRIDO[2,3-d]PYRIMIDINES AS KCC2 MODULATORS
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,240,832IRAK4 Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,613,173Apparatus and Method for Evaluating Physical Strength or Robustness of Solid Pharmaceutical Dosage Forms Based on an Impact Strike Test
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,502,398Combination Therapy for Treating Cancer
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,486,316Antibodies That Bind the Spike Protein of SARS-COV-2
In force
 · High confidence
AstraZeneca UK LimitedIn forceHigh confidence
US 12,291,524Amido Heteroaromatic Compounds
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 12,758,644Peptide Dendrons and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,758,646Combination of Antibody-Drug Conjugate and CDK9 Inhibitor
In force
 · High confidence
AstraZeneca UK Limited and Daiichi Sankyo Company, LimitedIn forceHigh confidence
US 12,667,541Dry Powder Formulation for Pulmonary Delivery and Methods of Use
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,678,444Substituted PYRAZINE-2-Carboxamides as HPK1 Inhibitors for the Treatment of Cancer
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
9 more term ends in 2043 · Pro
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
Upgrade to Pro
18 of these are in force and held by AstraZeneca AB.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited